期刊文献+

紫杉醇纳米混悬剂的制备与表征 被引量:3

Preparation and characterization of Paclitaxel nanosuspension
原文传递
导出
摘要 目的制备紫杉醇纳米混悬剂,并表征其理化性质。方法采用重结晶结合高压均质法制备紫杉醇纳米混悬剂,以纳米粒的粒径和Zeta电位为指标,考察紫杉醇纳米混悬剂的影响因素,并对制得的纳米混悬剂进行表征。结果紫杉醇纳米混悬剂的粒径为214.4 nm,跨距为0.46,平均Zeta电位为-22.7 mV,体系稳定。结论制备的纳米混悬剂处方简单、工艺稳定。 OBJECTIVE To prepare paclitaxel nanosuspension and characterize the physiochemical properties of Paclitaxel nanosuspension.METHODS Paclitaxel nanosuspension was prepared by high pressure homogenization combinded with recrystallization method.Regarding the particle size and the Zeta electric potential as index,the influence factors of praparation of Paclitaxel nanosuspension were studied.RESULTS The particle size of Paclitaxel nanoparticle was 214.4 nm with span of 0.46,as well as the Zeta electric potential was-22.7 mV.The nanosuspension system was stable.CONCLUSION Paclitaxel nanosuspension was successfully prepared by high pressure homogenization combinded with recrystallization method.
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第2期118-121,共4页 West China Journal of Pharmaceutical Sciences
关键词 紫杉醇 纳米混悬剂 重结晶 高压均质 Paclitaxel Nanosuspension Recrystallization High pressure homogenization
  • 相关文献

参考文献7

  • 1Anil KS,Alka G,Deepika A. Paclitaxel and its formulations[ J]. Inter J Pharmac, 2002, 235( 1 ) :179 - 192.
  • 2Jennifer S, Michael BS. Pharmacogenetics of paclitaxel metabolism [ J 1. Criti Rev in Onco/Henmto, 2007,61 ( 3 ) :222 - 229.
  • 3郑俊民.药用辅料手册[M].第4版.北京:化学工业出版社.2005:516-529.
  • 4Liversidge GG,Conzentino P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats [ J ]. Int J Pharm, 1995, ( 125 ) : 309 - 313.
  • 5Arturo B ,Andrea G ,Eleonora B ,et al. Synthesis of 7 -and 10 - spermine conjugates of paclitaxel and 10 -deacetyl -paclitaxel as potential prodrugs[ J]. Tetra Lett, 2006, 47:2667 -2670.
  • 6卞丽红 ,王洪权 ,张明伟 ,李素波 ,梅兴国 ,章扬培 .PLGA包裹的紫杉醇缓释微球的理化性质及抑瘤活性研究[J].高技术通讯,2005,15(7):57-60. 被引量:4
  • 7Zhang JA,Anyarambhatla G, Ma L,et al. Development and characterization of a novel Cremophor EL free liposome - based paclitaxel ( LEP - ETU) formulation [ J ]. Euro J Pharmac and Biopharmac, 2005, 59(1) : 177 -187.

二级参考文献1

共引文献4

同被引文献16

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部